Inotek reports $68 million net loss in 2015

Inotek Pharmaceuticals reported a net loss of $68 million in 2015 compared with $9.5 million in 2014, according to a press release. This included “$42.8 million in non-cash expenses associated with marking the 2020 convertible notes derivative liability to market value at the time of the conversions,” the release said.